Phase 2
Who we are
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
Window of Opportunity Study in Colorectal Cancer
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
A Trial of Ipatasertib in Combination With Atezolizumab
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease
Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer
A Study of ALX148 With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
